Pär Stattin

Research interests

Publications

• Epidemiology and Prevention of Prostate Cancer

  European Urology Oncology · 2021 · 10.1016/j.euo.2021.09.006

• Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

  Journal of Clinical Oncology · 2015 · 10.1200/jco.2014.59.1792

• Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study

  European Urology · 2012 · 10.1016/j.eururo.2012.08.001

• Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project

  Hypertension · 2012 · 10.1161/hypertensionaha.111.189258

• Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

  PLoS ONE · 2011 · https://doi.org/10.1371/journal.pone.0019059

• Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

  Aging Cell · 2010 · 10.1111/j.1474-9726.2010.00629.x

• Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

  JNCI Journal of the National Cancer Institute · 2010 · 10.1093/jnci/djq154

• Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy

  American Journal Of Pathology · 2010 · 10.2353/ajpath.2010.100070

• Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2010.29.1567

• Identification of a new prostate cancer susceptibility locus on chromosome 8q24

  Nature Genetics · 2009 · 10.1038/ng.444

• Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts

  PLoS Medicine · 2009 · 10.1371/journal.pmed.1000201

• Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies

  Annals of Internal Medicine · 2008 · https://doi.org/10.7326/0003-4819-149-7-200810070-00006

• Cumulative Association of Five Genetic Variants with Prostate Cancer

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa075819

• Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

  Nature Genetics · 2008 · https://doi.org/10.1038/ng.89

• Two Genome-wide Association Studies of Aggressive Prostate Cancer Implicate Putative Prostate Tumor Suppressor Gene DAB2IP

  JNCI Journal of the National Cancer Institute · 2007 · 10.1093/jnci/djm250

• Prospective Study of Hyperglycemia and Cancer Risk

  Diabetes Care · 2007 · 10.2337/dc06-0922

• Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

  International Journal of Cancer · 2003 · https://doi.org/10.1002/ijc.11375

• Obesity and colon cancer: Does leptin provide a link?

  International Journal of Cancer · 2003 · https://doi.org/10.1002/ijc.11668

• Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women

  International Journal of Cancer · 2003 · 10.1002/ijc.11529

• Prognostic value of the Gleason score in prostate cancer

  British Journal of Urology · 2002 · 10.1046/j.1464-410x.2002.02669.x

• Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

  The Prostate · 2002 · 10.1002/pros.10083

• Leptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent Study1

  The Journal of Clinical Endocrinology & Metabolism · 2001 · 10.1210/jcem.86.3.7328

• Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.

  International Journal of Oncology · 2000 · https://doi.org/10.3892/ijo.17.3.445

• Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study

  JNCI Journal of the National Cancer Institute · 2000 · 10.1093/jnci/92.23.1910

• Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

  The Prostate · 1998 · https://doi.org/10.1002/(sici)1097-0045(19980915)37:1<19::aid-pros4>3.0.co;2-3

Current projects

No projects listed.